
HYPD Stock Analysis
Hyperion DeFi, Inc.
HEALTHCARE
BIOTECHNOLOGY
Performance Overview
Trailing adjusted-close returns as of 2026-07-10. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 23, 2026
HYPD Stock Analysis: Why Hyperion DeFi, Inc. Scored 40% in Stock Value Finder
Hyperion DeFi, Inc.: An Educational StockValueFinder Review
Hyperion DeFi, Inc. (HYPD) is a biotechnology company operating within the healthcare sector. This article will provide an in-depth review of HYPD based on the metrics and data available through StockValueFinder.com, focusing on financial health, valuation, and market trends.
Why the StockValueFinder Score Matters
StockValueFinder evaluates stocks across various financial metrics to determine their overall strength and potential risks. For Hyperion DeFi, Inc., the stock has received a score of 40% with an AVOID rating. This rating suggests that based on the current data, HYPD may not be a suitable investment at this time due to several concerning financial indicators.
EPS Strength and Consistency
Earnings per share (EPS) is a critical metric for evaluating a company's profitability. High and consistent EPS values indicate strong earnings performance over time. For Hyperion DeFi, Inc., the system recorded that HYPD did not pass the EPS test. This result suggests that the company may be experiencing inconsistent or declining earnings, which can be a red flag for investors.
**Example:** A company with stable EPS growth of 5% year-over-year is generally more attractive than one showing erratic fluctuations or negative trends in its EPS numbers.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) measures how effectively a company uses capital to generate profits. StockValueFinder prefers companies with an ROIC of at least 10%. Hyperion DeFi, Inc.'s ROIC is -91.41%, which clearly does not meet this standard.
**Example:** A company with a high ROIC of 25% indicates that it uses its capital more efficiently than one with a lower ROIC like 8%.
Interest Coverage and Financial Safety
Interest coverage ratio shows how easily a company can pay off its interest expenses. StockValueFinder prefers companies with an interest coverage ratio of at least 6, indicating financial stability. Hyperion DeFi, Inc.'s test result did not pass this criterion.
**Example:** A company with an interest coverage ratio of 10 is in better financial health than one with a ratio of 3, as it can more easily cover its debt obligations.
Debt Payback and Balance Sheet Discipline
Debt payback years measure how long it would take for a company to repay all its debts using current earnings. StockValueFinder prefers companies that can repay their debts within three years or less. Hyperion DeFi, Inc.'s debt payback period is -0.53 years, which passes this test.
**Example:** A company with a debt payback period of 2 years is in better financial shape than one with a period of 8 years, as it can repay its debts faster and has lower long-term risk.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio helps investors assess whether a stock's price reflects fair value relative to earnings. StockValueFinder prefers a P/E ratio below 15 for valuation discipline. Hyperion DeFi, Inc.'s current P/E ratio is -0.28, which passes this test.
**Example:** A company with a P/E of 10 might be considered undervalued compared to one with a P/E of 30, assuming the business quality and growth prospects are similar.
Moving Average Trend and Entry Timing
The moving average signal for Hyperion DeFi, Inc. is WEAK TREND, indicating that the stock price has been declining relative to its short-term averages. The entry signal is N/A, meaning there is no specific timing indicator based on current trends.
**Example:** A strong trend would be indicated by a rising 50-day moving average crossing above a rising 200-day moving average, suggesting continued upward momentum in the stock price.
Overall Financial Strengths and Weaknesses
Hyperion DeFi, Inc.'s financial profile is mixed. The company passes the debt payback test but fails on EPS consistency, ROIC, interest coverage, and trend signals. This suggests that while HYPD may have some short-term liquidity advantages, it struggles with profitability and efficient capital use.
Risks and Limitations
Investing in biotechnology companies like Hyperion DeFi, Inc., involves significant risks due to the high costs of research and development, regulatory hurdles, and uncertain market acceptance. The current financial metrics indicate that HYPD faces challenges in maintaining consistent earnings and managing debt effectively.
Additionally, the WEAK TREND signal suggests that the stock price is not showing positive momentum at this time, which may discourage short-term traders looking for upward movement.
Educational Conclusion
Understanding how to evaluate stocks using financial ratios like EPS, ROIC, P/E ratio, and interest coverage helps investors make informed decisions. Hyperion DeFi, Inc.'s current metrics suggest that it does not meet the criteria set by StockValueFinder for a strong investment at this time due to its poor earnings performance, low capital efficiency, and weak trend signals.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.